Erectile dysfunction (ED) is one of the extrahepatic manifestations of hepatitis C virus infection that greatly affects patients' quality of life. Unfortunately, some of the drugs used for HCV treatment may have a negative impact on the patient's erectile function such as the pegylated interferon. Currently, with the introduction of directacting antiviral drugs, there are scarce data in the literature about its potential impact on erectile function. In these settings, we aimed to assess the impact of sofosbuvir-based therapy on male erectile function
Peg-interferon (PegIFN)α2a or PegIFNα2b plus ribavirin (RBV) is the standard therapy for chronic hep...
Abstract Background COVID-19 infection has been linked with erectile dysfunction, which has also rai...
We aimed to determine the sexual problems and the prevalence of erectile dysfunction (ED) in patient...
Erectile dysfunction (ED) is one of the extrahepatic manifestations of hepatitis C virus infection t...
We evaluated the prevalence of erectile dysfunction in 207 patients with HCV infection (identified b...
Background/Aim: The frequency of sexual dysfunction (SD) is not well known in patients with chronic ...
Here, we aimed to determine the prevalence of erectile dysfunction (ED) among HIV-infected men and i...
A high prevalence of erectile dysfunction /ED) has been reported in HIV-infected men. However factor...
Introduction. Erectile dysfunction (ED) is highly prevalent among human immunodeficiency virus-serop...
Increasing numbers of HIV-positive men receiving protease inhibitors (PI) complain of erectile dysfu...
Introduction. Chronic liver diseases are often accompanied by hypogonadism, testicular atrophy, and ...
BACKGROUND: Here, we aimed to determine the prevalence of erectile dysfunction (ED) among HIV-infect...
The relationship between erectile dysfunction drugs and the immune system is unclear. There have bee...
Altres ajuts: The author(s) disclosed receipt of the following financial support for the research, a...
International audienceINTRODUCTION: In men, erectile dysfunction (ED) is an important issue. Data co...
Peg-interferon (PegIFN)α2a or PegIFNα2b plus ribavirin (RBV) is the standard therapy for chronic hep...
Abstract Background COVID-19 infection has been linked with erectile dysfunction, which has also rai...
We aimed to determine the sexual problems and the prevalence of erectile dysfunction (ED) in patient...
Erectile dysfunction (ED) is one of the extrahepatic manifestations of hepatitis C virus infection t...
We evaluated the prevalence of erectile dysfunction in 207 patients with HCV infection (identified b...
Background/Aim: The frequency of sexual dysfunction (SD) is not well known in patients with chronic ...
Here, we aimed to determine the prevalence of erectile dysfunction (ED) among HIV-infected men and i...
A high prevalence of erectile dysfunction /ED) has been reported in HIV-infected men. However factor...
Introduction. Erectile dysfunction (ED) is highly prevalent among human immunodeficiency virus-serop...
Increasing numbers of HIV-positive men receiving protease inhibitors (PI) complain of erectile dysfu...
Introduction. Chronic liver diseases are often accompanied by hypogonadism, testicular atrophy, and ...
BACKGROUND: Here, we aimed to determine the prevalence of erectile dysfunction (ED) among HIV-infect...
The relationship between erectile dysfunction drugs and the immune system is unclear. There have bee...
Altres ajuts: The author(s) disclosed receipt of the following financial support for the research, a...
International audienceINTRODUCTION: In men, erectile dysfunction (ED) is an important issue. Data co...
Peg-interferon (PegIFN)α2a or PegIFNα2b plus ribavirin (RBV) is the standard therapy for chronic hep...
Abstract Background COVID-19 infection has been linked with erectile dysfunction, which has also rai...
We aimed to determine the sexual problems and the prevalence of erectile dysfunction (ED) in patient...